Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MiniMed Group, Inc.MMED · Entity 3758 | EVP, Chief Financial Officer | July 28, 2026 | July 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MiniMed Group, Inc.
Report date July 28, 2026 · Filed July 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 362,707 |
Reported balance
After 2026-07-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-28 · Tax withholding · Disposed 23,301 · Balance 362,707 F1: Represents shares of Common Stock that have been withheld by MiniMed Group Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock that have been withheld by MiniMed Group Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").
F2: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 29, 2026 23:10 UTC | MiniMed Group, Inc. MMED · Entity 3758 | Tax withholdingCommon Stock | 23,301 | $17.67 | $411,728.67 |
DisclosureSEC source: 0002111465-26-000004 · wk-form4_1785366625.xml · nonDerivative · entry 1 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,707 F1 · shares: Represents shares of Common Stock that have been withheld by MiniMed Group Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:40 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 22,057 | $0.00 | $0.00 |
DisclosureSEC source: 0002111465-26-000002 · wk-form4_1783374050.xml · nonDerivative · entry 2 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,008 F3 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:40 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 94,550 | $0.00 | $0.00 |
DisclosureSEC source: 0002111465-26-000002 · wk-form4_1783374050.xml · nonDerivative · entry 1 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,951 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:24 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 70,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017828 · wk-form4_1773444267.xml · nonDerivative · entry 3 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,896 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F6 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F6 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:24 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 127,609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017828 · wk-form4_1773444267.xml · nonDerivative · entry 2 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,609 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F5 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on July 28, 2026, July 28, 2027 and July 28, 2028. F5 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on July 28, 2026, July 28, 2027 and July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:24 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 70,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017828 · wk-form4_1773444267.xml · nonDerivative · entry 1 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,896 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F3 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 28, 2028. F3 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:30 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantEmployee Stock Option (Right to Buy) · Derivative | 84,176 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001628280-26-016849 · wk-form4_1773261026.xml · derivative · entry 2 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,176 Underlying: Common Stock · 84,176 shares Expires 2036-03-09 F3 · derivative.exercise_date: The option vests 33% on each of March 9, 2028 and March 9, 2029, and 34% on March 9, 2030. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:30 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantPerformance-Based Restricted Stock Units · Derivative | 27,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-016849 · wk-form4_1773261026.xml · derivative · entry 1 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,778 Underlying: Common Stock · 27,778 shares Expires not disclosed F1 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of MMED common stock. The performance-based restricted stock units vest on March 9, 2027, subject to MMED common stock achieving a closing price per share of at least $32.05 as of the Divestment Date (as defined in the Separation Agreement, dated March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US Holdco 2, Inc.). F1 · derivative.exercise_date: Each performance-based restricted stock unit represents a contingent right to receive one share of MMED common stock. The performance-based restricted stock units vest on March 9, 2027, subject to MMED common stock achieving a closing price per share of at least $32.05 as of the Divestment Date (as defined in the Separation Agreement, dated March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US Holdco 2, Inc.). F2 · derivative.expiration_date: The later of March 9, 2027 or the Divestment Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.